|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Employee Stock Option (1) (10) | $ 6.52 | 02/22/2019 | M(1) | 16,800 | 05/09/2014 | 05/09/2019 | Common Stock | 16,800 | $ 0 | 0 | D | ||||
Employee Stock Option (11) | $ 8.36 | 05/14/2015 | 05/14/2020 | Common Stock | 70,000 | 70,000 | D | ||||||||
Employee Stock Option (12) | $ 9.35 | 05/15/2016 | 05/15/2021 | Common Stock | 72,000 | 72,000 | D | ||||||||
Employee Stock Option (13) | $ 10.35 | 05/10/2017 | 05/10/2022 | Common Stock | 72,000 | 72,000 | D | ||||||||
Employee Stock Option (14) | $ 15.55 | 05/10/2018 | 05/10/2023 | Common Stock | 72,000 | 72,000 | D | ||||||||
Employee Stock Option (15) | $ 19.45 | 05/09/2019 | 05/09/2024 | Common Stock | 72,000 | 72,000 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Kouzelos Michael P C/O CBIZ, INC. 6050 OAK TREE BOULEVARD SOUTH CLEVELAND, OH 44131 |
President, Employee Services |
/s/ Michael W Gleespen, attorney-in-fact for Michael P Kouzelos | 02/26/2019 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Exercise and sale of Employee Stock Options granted 05-09-2013 at $6.52 exercise price, expiring 05-09-2019. |
(2) | Cashless Hold: exercise of options and sale of shares sufficient to cover only exericise price, taxes and fees. |
(3) | Consists of restricted shares issued under the CBIZ, Inc. 2014 Stock Incentive Plan. Restrictions lapse with respect to 25% of the granted restricted shares on each of the first, second, third and fourth anniversaries of the grant date, provided grantee is still providing services to CBIZ on such vesting dates, and grantee has complied with the applicable CBIZ client non-interference policy. |
(4) | Exercise and sale of Employee Stock Options granted 04-04-2011 at $7.41 exercise price, expiring 04-04-2017. |
(5) | Exercise and sale of Employee Stock Options granted 05-22-2012 at $5.87 exercise price, expiring 05-22-2018. |
(6) | Exercise and sale of Employee Stock Options granted 5-13-2011 at $6.75 exercise price, expiring 5-13-16. |
(7) | Restricted Common Stock previously reported as a separate non-derivative from common stock, affecting the total number of shares of common stock. This stock will no longer be reported separate from common stock. |
(8) | Surrender of stock to satisfy withholding obligation on vesting of restricted stock |
(9) | Weighted average sale price of price range between $21.25 and $21.38. Will provide upon request number of shares sold at each separate price. |
(10) | Annual equity compensation award granted on 5-9-2013, vesting 25% in each of the four anniversaries following the grant date. |
(11) | Annual equity compensation award granted on 5-14-2014, vesting 25% in each of the four anniversaries following the grant date. |
(12) | Consists of Option granted 05/15/2015, vesting in 25% increments each year beginning 05/15/2016, and expiring on 05/15/2021. |
(13) | Consists of Options granted 05/10/2016, vesting in 25% increments each year beginning 05/10/2017, and expiring on 05/10/2022. |
(14) | Consists of Options granted of5/10/2017 vesting in 25% increments each year beginning 05/10/2018 and expiring on 05/10/2023. |
(15) | Consists of Options granted on 05/09/2018 vesting in 25% increments each year beginning 05/09/2019 and expiring on 05/09/2024. |